CASI PHARMACEUTICALS, INC. Operating Lease Liability
CASI PHARMACEUTICALS, INC. had Operating Lease Liability of $1.34 million as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2023-04-26
- 2022-12-31: Operating Lease, Liability $1.34M.
- 2022-09-30: Operating Lease, Liability $1.56M.
- 2022-06-30: Operating Lease, Liability $1.90M.
- 2022-03-31: Operating Lease, Liability $1.88M.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-12-31 | $1.34M 20-F · filed 2023-04-26 |
| 2022-09-30 | $1.56M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.90M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.88M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.17M 20-F · filed 2023-04-26 |
| 2021-09-30 | $2.65M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.89M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.58M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.90M 10-K · filed 2022-03-28 |
| 2020-09-30 | $2.36M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.60M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.88M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.20M 10-K · filed 2021-03-30 |
| 2019-09-30 | $2.43M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.78M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.96M 10-Q · filed 2019-05-15 |